DOCSLIB.ORG

PERIPHERAL ARTERIAL DISEASES Postgrad Med J: First Published As 10.1136/Pgmj.22.243.22 on 1 January 1946

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PERIPHERAL ARTERIAL DISEASES Postgrad Med J: First Published As 10.1136/Pgmj.22.243.22 on 1 January 1946 PERIPHERAL ARTERIAL DISEASES Postgrad Med J: first published as 10.1136/pgmj.22.243.22 on 1 January 1946. Downloaded from By SAUL S. SAMUELS, A.M., M.D. New York, N.Y. Arterial Diseases arteries that might be mentioned, but clinical Peripheral evidence of which is difficult to determine. They This new specialty has evolved within the past are encountered so infrequently that it hardly twenty years into a separate and distinct branch of seems important to devote much time to them. medicine and surgery. In its infancy it was rele- Among these may be mentioned syphilitic arteritis, gated to the internist who had some special interest tuberculosis of the peripheral arteries and certain in this work, just as in the early days of urology an non-specific forms of peripheral arteritis, which acquaintance with venereal diseases was sufficient have as yet been incompletely studied. for the designation of specialist in this field. In the field of functional disturbances of the peripheral arterial system, we consider two main General sub-groups. The first, and more important of Considerations these is Raynaud's Disease. This is a disturbance The peripheral arterial diseases may be separated of the control mechanism of the peripheral arteri- into two definite groups. The first and more oles which causes frequent attacks of vasospasm important is that of the changes in the arterial in the extremities and in the various acral parts of walls. These two groups may be again sub- the body, such as the tip of the nose, tongue and divided so that in the organic field we recognise ears. It is frequently associated with a peculiar two major varieties of organic arterial disease in trophic disturbance of the skin, hands, arms, face the extremities. The most common of these, and and chest. This is a distinct variety of sclero- by far the most important from the standpoint of derma. Dermatologists seem to distinguish this frequency of occurrence, is arteriosclerosis. At this form of scleroderma from that which is not en- it be well to differentiate the term countered in Disease and which point might Raynaud's appears Protected by copyright. arteriosclerosis from the disease process known as to be preceded by an inflammatory reaction in the arteriosclerosis obliterans. The practical signifi- dermal tissues. Another frequent accompaniment cance of this distinction lies in the fact that arterio- of Raynaud's Disease is a peculiar variety of rheu- sclerosis, that is to say, definite structural changes matoid arthritis, involving usually the small joints in the walls of the arteries may be present to a of the hands and feet and in some instances the great degree without in any way interfering with larger joints of the body. the arterial onflow. In other words, the mere The other functional derangement of the peri- presence of arteriosclerosis of the peripheral pheral arterial system is known as erythromelalgia arteries as shown by roentgen films does not in or Weir Mitchell's Disease. This interesting but itself indicate arterial insufficiency in that parti- extremely rare disease will be mentioned here cular individual. When, however, the element of merely for the sake of completeness, but from a obstruction is added to arteriosclerosis, induced practical standpoint it is so seldom encountered as either by progressive narrowing of the lumen of to require comparatively little consideration. Its the artery or by encroachment on its blood carrying main features are a paralysis of the vasomotor http://pmj.bmj.com/ capacity by the formation of thrombi on mural mechanism to such an extent that an almost plaques, insufficiency of the arterial flow may then constant vasodilatation is obtained in all four be expected. In such a case the proper termino- extremities. In some instances, however, the dis- logy is arteriosclerosis obliterans. The- frequent turbance may be confined to a single limb. I have association of an arteriosclerotic process with seen such a case resulting from severe trauma to an diabetes mellitus accentuates the importance of upper extremity. According to Brown of the Mayo this disease in the field of peripheral vascular Clinic, the diagnostic features of erythromelalgia diseases. Whether or no the presence of diabetes are severe burning pain in the affected extremities on September 26, 2021 by guest. intensifies the arteriosclerotic process, particularly which symptoms are relieved only by immersion of in the uncontrolled diabetic patient, is still open the affected parts in ice-cold water. He stresses to question. In any event the combination of the the importance of this means of obtaining relief as two adds considerable difficulty to the treatment an essential factor in arriving at a diagnosis. It is of gangrene of the extremities. important to recognise this fact because frequently The other important organic arterial disease is both in practice and in the literature of peripheral thromboangiitis obliterans, commonly known as vascular diseases the error has been made of diag- Buerger's Disease. This will be described in nosing erythromelalgia merely on the basis of red- greater detail in the following pages. Aside from ness and perhaps some swelling with burning pain arteriosclerosis and thromboangiitis obliterans, of one or more extremities. It must not be for- there are other organic diseases of the peripheral gotten that the condition known as rubor, parti- PERIPHERAL ARTERIAL DISEASES. SAUL S. SAMUELS, A.M., M.D. 23 Postgrad Med J: first published as 10.1136/pgmj.22.243.22 on 1 January 1946. Downloaded from .. ..... ....... ...... .... ....... FIG. 2.-Gangrene in thromboangiitis obliterans. Protected by copyright. 2: http://pmj.bmj.com/ on September 26, 2021 by guest. .?..'^......' .:...... FIG. i.-Samuels' Test for plantar ischemia. FIG. 3.-Same case healed without operation. M.D. 24 PERIPHERAL ARTERIAL DISEASES. SAUL S. SAMUELS, A.M., Postgrad Med J: first published as 10.1136/pgmj.22.243.22 on 1 January 1946. Downloaded from FIG. 4.-Diabetic gangrene of heel. Protected by copyright. http://pmj.bmj.com/ on September 26, 2021 by guest. FIG. 5.-Same case healed. PERIPHERAL ARTERIAL DISEASES Januacav,, I946 Postgrad Med J: first published as 10.1136/pgmj.22.243.22 on 1 January 1946. Downloaded from cularly in the lower extremities, is frequently the peripheral arterial system before passing final present in long-standing cases of arteriosclerosis judgment as to the cause of the symptoms. obliterans or in thromboangiitis obliterans and to Just as in coronary artery disease where the the inexperienced observer the appearance of this general clinical picture is frequently called. angina one stage, namely rubor, may induce an erroneous pectoris, so in the field of arterial insufficiency of diagnosis of erythromelalgia. the lower extremities one groups all the symptoms Here I wish to stress the fact that in recent together in the category of intermittent claudica- years there has been a great tendency to over- tion. In its classic form this syndrome consists of emphasise the importance of vasomotor change, a feeling of fatigue or actual cramp in the calf of particularly vasospasm, in the organic arterial the affected leg induced by walking, particularly diseases. Unfortunately, therapy of the organic fast walking or climbing a flight of steps. Thus, diseases has been directed in many instances to the after a variable distance, often depending upon the elimination of vasospasm. The fallacy of this severity of the arterial disease, the patient is forced concept lies in the fact that the vasomotor dis- to stop because of disabling symptoms. After a turbances associated with the organic arterial rest period of a moment or so, the patient is able to diseases are for the most part confined to the very proceed for a comparatively short distance after early stages of these diseases and are comparatively which the disabling symptom reappears. This infrequent in the later stages .where the organic classic form of intermittent claudication does not, element is a predominant feature. In accordance however, always manifest itself in every case. As with this misconception, too many operative pro- mentioned previously, it may resemble a form'of cedures, particularly sympathectomy, have been sciatic pain or it may appear as a tightening of the advocated and been performed unnecessarily in small muscles of the foot, inducing a cramp-like cases where simpler methods of treatment were seizure which does not allow the patient to proceed indicated. in walking, or there may be numbness of the toes or of the entire foot or Paresthesias of leg. Protected by copyright. various kinds can also be brought to light after Symptomatology walking a short distance and may be the only sign At the outset it is important to know that the called to the patient's notice that something un- symptoms of arterial insufficiency in the extremi- usual is occurring in the feet. Any of these symp- ties are extremely variable and may be absent toms may be accompanied by subjective coldness entirely in the presence of advanced occlusive of either the toes or the entire foot of the affected disease, or they may simulate many other common extremity. This is particularly true in those cases conditions. For these reasons, it is important to where there has been a fairly recent interference lay more stress on the objective findings elicited by with arterial flow such as in a thrombosis of a main a careful physical examination, rather than on the vessel. Arriving at a diagnosis merely on symp- patient's statement of symptoms. Failure fo toms alone has, of course, led to many strange recognise this point has resulted in numerous in- therapeutic procedures. A prescription of arch correct diagnoses on the part of excellent practi- supports, of specially constructed shoes, of various tioners and specialists, who apparently rely too intricate strappings of the feet and legs have all http://pmj.bmj.com/ much upon the patient's story.
Load more

Recommended publications
  • The Evolution of Invasive Cerebral Vasospasm Treatment in Patients
    Neurosurgical Review (2019) 42:463–469 https://doi.org/10.1007/s10143-018-0986-5 ORIGINAL ARTICLE The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia—continuous selective intracarotid nimodipine therapy in awake patients without sedation Andrej Paľa1 & Max Schneider1 & Christine Brand 1 & Maria Teresa Pedro1 & Yigit Özpeynirci2 & Bernd Schmitz2 & Christian Rainer Wirtz1 & Thomas Kapapa1 & Ralph König1 & Michael Braun2 Received: 16 February 2018 /Revised: 1 May 2018 /Accepted: 17 May 2018 /Published online: 26 May 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Cerebral vasospasm (CV) and delayed cerebral ischemia (DCI) are major factors that limit good outcome in patients with spontaneous subarachnoid hemorrhage (SAH). Continuous therapy with intra-arterial calcium channel blockers has been intro- duced as a new step in the invasive treatment cascade of CV and DCI. Sedation is routinely necessary for this procedure. We report about the feasibility to apply this therapy in awake compliant patients without intubation and sedation. Out of 67 patients with invasive endovascular treatment of cerebral vasospasm due to spontaneous SAH, 5 patients underwent continuous superselective intracarotid nimodipine therapy without intubation and sedation. Complications, neurological improvement, and outcome at discharge were summarized. Very good outcome was achieved in all 5 patients. The Barthel scale was 100 and the modified Rankin scale 0–1 in all cases at discharge. We found no severe complications and excellent neurological monitoring was possible in all cases due to patients’ alert status. Symptoms of DCI resolved within 24 h in all 5 cases. We could demonstrate the feasibility and safety of selective intracarotid arterial nimodipine treatment in awake, compliant patients with spontaneous SAH and symptomatic CVand DCI.
    [Show full text]
  • Calcium Channel Blockers Yaser Alahamd, Hisham Ab Ib Swehli, Alaa Rahhal, Sundus Sardar, Mawahib Ali Mohammed Elhassan, Salma Alsamel and Osama Ali Ibrahim
    Chapter Calcium Channel Blockers Yaser Alahamd, Hisham Ab Ib Swehli, Alaa Rahhal, Sundus Sardar, Mawahib Ali Mohammed Elhassan, Salma Alsamel and Osama Ali Ibrahim Abstract Vasospasm refers to a condition in which an arterial spasm leads to vasoconstric- tion. This can lead to tissue ischemia and necrosis. Coronary vasospasm can lead to significant cardiac ischemia associated with symptomatic ischemia or cardiac arrhythmia. Cerebral vasospasm is an essential source of morbidity and mortality in subarachnoid hemorrhage patients. It can happen within 3–15 days with a peak incidence at 7 days after aneurysmal subarachnoid hemorrhage (SAH). Calcium channel blockers are widely used in the treatment of hypertension, angina pectoris, cardiac arrhythmias, and other disorders like SAH vasospasm related and Migraine. The specific treatment of cerebral vasospasm helps improving cerebral blood flow to avoid delayed ischemic neurologic deficit by reducing ICP, optimizing the rate of cerebral oxygen demand, and enhancing cerebral blood flow with one of the following approaches: indirect pharmacological protection of brain tissue or direct mechanical dilation of the vasospastic vessel. Nimodipine is the standard of care in aneurysmal SAH patients. Nimodipine 60 mg every 4 hours can be used for all patients with aneurysmal SAH once the diagnosis is made for 21 days. Keywords: coronary vasospasm, cerebral vasospasm, calcium channel blockers, cerebral blood flow, nimodipine 1. Introduction Vasospasm is a condition which is associated with an arterial spasm and vasocon- striction, which may lead to tissue ischemia and necrosis. Coronary vasospasm can lead to significant cardiac ischemia associated with symptomatic ischemia or cardiac arrhythmia. Cerebral vasospasm may arise as a complication of subarachnoid hem- orrhage (SAH).
    [Show full text]
  • Traumatic Brain Injury and Intracranial Hemorrhage–Induced Cerebral Vasospasm:A Systematic Review
    NEUROSURGICAL FOCUS Neurosurg Focus 43 (5):E14, 2017 Traumatic brain injury and intracranial hemorrhage–induced cerebral vasospasm: a systematic review Fawaz Al-Mufti, MD,1,2 Krishna Amuluru, MD,2 Abhinav Changa, BA,2 Megan Lander, BA,2 Neil Patel, BA,2 Ethan Wajswol, BS,2 Sarmad Al-Marsoummi, MBChB,5 Basim Alzubaidi, MD,1 I. Paul Singh, MD, MPH,2,4 Rolla Nuoman, MD,3 and Chirag Gandhi, MD2–4 1Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick; Departments of 2Neurosurgery, 3Neurology, and 4Radiology, Rutgers University, New Jersey Medical School, Newark, New Jersey; and 5University of North Dakota, Grand Forks, North Dakota OBJECTIVE Little is known regarding the natural history of posttraumatic vasospasm. The authors review the patho- physiology of posttraumatic vasospasm (PTV), its associated risk factors, the efficacy of the technologies used to detect PTV, and the management/treatment options available today. METHODS The authors performed a systematic review in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using the following databases: PubMed, Google Scholar, and CENTRAL (the Cochrane Central Register of Controlled Trials). Outcome variables extracted from each study included epidemiology, pathophysiology, time course, predictors of PTV and delayed cerebral ischemia (DCI), optimal means of surveillance and evaluation of PTV, application of multimodality monitoring, modern management and treatment op- tions, and patient outcomes after PTV. Study types were limited to retrospective chart reviews, database reviews, and prospective studies. RESULTS A total of 40 articles were included in the systematic review. In many cases of mild or moderate traumatic brain injury (TBI), imaging or ultrasonographic studies are not performed.
    [Show full text]
  • Variant Angina
    maco har log P y: r O la u p c e n s a A Fumimaro Takatsu, Cardiol Pharmacol 2015, 4:3 v c o c i e d r s Open Access a s Cardiovascular Pharmacology: DOI: 10.4172/2329-6607.1000143 C ISSN: 2329-6607 Letter to Editor OpenOpen Access Access Variant Angina: Why do you Ignore Spasm of Coronary Arteries? Fumimaro Takatsu MD* Department of Cardiology, Takatsu Naika Junkankika, 2-4-7 Mikawaanjo-Hommachi, Anjo, Aichi, Japan Introduction perform provocation of spasm; if possible (once the patient returned to a ward, I explain on the vasospasm and get written informed consent), Many authors reported on variant (form of) angina (Prinzmetal’s before the patient and families leave the hospital because almost all Variant Angina, vasospastic angina) till 1990s on the various aspects of of patients and families cannot realize electrocardiographic findings this disease. However, in this century, articles on this very important and would not have medications. Moreover, although not so frequent, disease have become very few. One reason of this apparent ignorance some patients with chest discomfort only on effort have no significant of vasospastic angina may be caused by a report by Cianflone et al. in coronary narrowing have vasospasm. 2000 [1], in which they studied only 34 patients and concluded that vasospasm is much less in Caucasian peoples. A scientific research, Complications especially in clinical medicine, at least more than several hundred Coronary vasospasm, of course, if prolonged, can cause acute patients must be studied for some conclusion. Thus, I feel, their result myocardial infarction by itself or by causing intraluminal thrombus or is very questionable and responsibility of American Heart Association rupture of minor atherosclerotic plaque.
    [Show full text]
  • Calcium Channel Blockers Cannot Prevent Pure Vasospastic Myocardial Infarction
    Postgrad Med J: first published as 10.1136/pgmj.63.735.41 on 1 January 1987. Downloaded from Postgraduate Medical Journal (1987) 63, 41-44 Calcium channel blockers cannot prevent pure vasospastic myocardial infarction P. Depelchin and S. Degre Department ofMedical Cardiology, H6pital Academique Erasme, Universite Libre de Bruxelles, 808 route de Lennik, 1070 Bruxelles, Belgium. Summary: Coronary artery spasm is a recognized cause of myocardial infarction. This report describes a case of myocardial infarction attributed to pure coronary spasm which was halted by a double perfusion with streptokinase and nitroglycerin. Further coronary artery spasm leading to a myocardial infarction could not be avoided several weeks later, although the patient was left on calcium channel blocker therapy. The two attacks were not preceded by warning angina pectoris, contrary to accepted belief. The best objective ofend-point drug therapy and its assessment in vasospastic angina are discussed. Introduction Coronary artery spasm alone or superimposed on an atheromatous lesion is now recognized as a cause of myocardial infarction.' Our therapeutic approach has therefore been directed not only towards treating by copyright. factors which increase myocardial oxygen demand but also to modulating smooth-muscle contraction res- ponsible for the coronary artery spasm. Calcium channel blockers and nitroglycerin compounds are potent smooth-muscle relaxing drugs and are effective in suppressing spasm-induced angina. However, nitroglycerin, even intracoronary administered after induced coronary spasms, has sometimes been unable to reverse the spasm.2 We present a patient free from http://pmj.bmj.com/ arteriosclerotic coronary artery disease who de- veloped pure vasospastic myocardial infarction in spite of calcium channel blocking therapy.
    [Show full text]
  • Coronary Vasospasm Associated with Hyperthyroidism
    Case Report Coronary Spasm Associated with Hyperthyroidism Acta Cardiol Sin 2010;26:48-51 Coronary Vasospasm Associated with Hyperthyroidism Jiunn-Wen Lin,1 Wei-Cheng Lian2 and Tin-Kwang Lin1 Acute myocardial ischemia is a rare and possibly life-threatening manifestation of hyperthyroidism. We describe a 48-year-old woman with severe coronary vasospasm associated with hyperthyroidism. The patient presented with chest pain and increasing shortness of breath for several days. Acute non-ST elevation myocardial infarction was diagnosed. Coronary angiography revealed diffuse vasoconstriction which was relieved by intracoronary nitroglycerin. Subsequently, she was diagnosed with hyperthyroidism and treated with antithyroid therapy and an oral calcium channel blocker. After restoration of euthyroidism, she remained free of chest pain. Our report reminds readers that severe coronary spasm might be sometimes associated with simultaneous hyperthyroidism, especially in patients without risk factors of atherosclerosis. Key Words: Acute myocardial infarction · Coronary vasospasm · Hyperthyroidism INTRODUCTION department with a two-day history of chest pain and in- creasing shortness of breath. The episodes of pain varied The cardiovascular system is very sensitive to thyroid in length and were aggravated by exercise. On direct hormone, and a wide spectrum of cardiac changes has questioning, she did not have palpitation, body weight been recognized in hyperthyroidism.1 Acute myocardial loss, heat intolerance, or resting tremor. She denied any ischemia is a rare and possibly life-threatening manifesta- history of cardiovascular disease and was premeno- tion of hyperthyroidism. However, in the absence of fixed pausal. She denied smoking, drinking alcohol or illicit coronary artery disease, hyperthyroidism is rarely associ- drug use.
    [Show full text]
  • Peripheral Artery Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
    ACCF/AHA Pocket Guideline November 2011 Management of Patients With Peripheral Artery Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) Adapted from the 2005 ACCF/AHA Guideline and the 2011 ACCF/AHA Focused Update Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery © 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc. The following material was adapted from the 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease J Am Coll Cardiol 2011; 58:2020-2045 and the 2005 ACC/AHA guidelines for the management of the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) J Am Coll Cardiol 2006;47:1239-312. This pocket guideline is available on the World Wide Web sites of the American College of Cardiology (cardiosource.org) and the American Heart Association (my.americanheart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, e-mail: [email protected]; phone: 212-633-3813; fax: 212-633-3820. Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier’s permission department at [email protected]. B Contents 1. Introduction
    [Show full text]
  • Prinzmetal Variant Angina Associated with Multiple Sclerosis
    J Am Board Fam Pract: first published as 10.3122/jabfm.17.1.71 on 10 March 2004. Downloaded from Prinzmetal Variant Angina Associated with Multiple Sclerosis Scott Joing, MD, Robyn Casey, MD, and Les Forgosh, MD We report the case of a young woman with an acute coronary syndrome in the setting of a multiple scle- rosis exacerbation. A connection between the 2, possibly caused by spinal cord pathology, is suggested. (J Am Board Fam Pract 2004;17:71–3.) Prinzmetal variant angina is characterized by an- ages, suggesting a more acute process of demyeli- gina secondary to coronary artery vasospasm,1 typ- nation. The patient denied any previous episodes of ically at rest, associated with transient ST-segment chest pain as well as any cardiac history, hyperten- deviations.2 Further diagnostic workup using an- sion, hypercholesterolemia, or respiratory prob- giography may reveal coronary arteries with or lems. Past medical history included MS, depres- without atherosclerotic narrowings.1 Multiple scle- sion, possible seizure disorder, tonsillectomy, and rosis (MS) is typically a relapsing-remitting neuro- appendectomy. She was adopted, and her family logic disorder involving demyelinated plaques, history is unknown. Her usual medications include 3 which slow or block conduction along nerves. Lit- 150 mg of ranitidine twice daily, 50 mg of sertraline erature search reveals one case report indicating a twice daily, 100 mg of amantadine twice daily, 100 4 causal relationship between these 2 diseases. We mg of carbamazepine twice daily, norethindrone present an additional case involving a 38-year-old and ethinyl estradiol, propoxyphene napsylate as patient who experienced Prinzmetal variant angina needed, and interferon ␤1a once per week.
    [Show full text]
  • Safety and Efficacy of Sildenafil Citrate in Reversal of Cerebral Vasospasm: a Feasibility Study Kanchan K
    OPEN ACCESS Editor-in-Chief: Surgical Neurology International James I. Ausman, MD, PhD For entire Editorial Board visit : University of California, Los http://www.surgicalneurologyint.com Angeles, CA, USA Original Article Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility study Kanchan K. Mukherjee, Shrawan K. Singh1, Virender K. Khosla, Sandeep Mohindra, Pravin Salunke Departments of Neurosurgery and 1Urology, PGIMER, Chandigarh, India E-mail: Kanchan K. Mukherjee- [email protected]; Shrawan K. Singh- [email protected]; Virender K Khosla- [email protected]; Sandeep Mohindra- [email protected]; *Pravin Salunke - [email protected] *Corresponding author Received: 1 November 11 Accepted: 13 December 11 Published: 21 January 12 This article may be cited as: Mukherjee KK, Singh SK, Khosla VK, Mohindra S, Salunke P. Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility study. Surg Neurol Int 2012;3:3. Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/3/92164 Copyright: © 2012 Mukherjee KK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Objective: Cerebral vasospasm is the commonest cause for mortality and morbidity in patients following clipping of a ruptured aneurysm. Selective phosphodiesterase (PDE) inhibitor like sildenafil acts as a vasodilator. The objective of this study was to evaluate the safety and feasibility of oral sildenafil citrate in patients with symptomatic refractory vasospasm. Methods: A total of 832 patients with aneurysmal subarachnoid bleed were operated in 4 years.
    [Show full text]
  • Medical Management of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage: a Review of Current and Emerging Therapeutic Interventions
    Hindawi Publishing Corporation Neurology Research International Volume 2013, Article ID 462491, 10 pages http://dx.doi.org/10.1155/2013/462491 Review Article Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions Peter Adamczyk, Shuhan He, Arun Paul Amar, and William J. Mack Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA Correspondence should be addressed to Peter Adamczyk; [email protected] Received 26 November 2012; Accepted 23 March 2013 Academic Editor: Jay Mocco Copyright © 2013 Peter Adamczyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cerebral vasospasm is a major source of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). Evidence suggests a multifactorial etiology and this concept remains supported by the assortment of therapeutic modalities under investigation. The authors provide an updated review of the literature for previous and recent clinical trials evaluating medical treatments in patients with cerebral vasospasm secondary to aSAH. Currently, the strongest evidence supports use of prophylactic oral nimodipine and initiation of triple-H therapy for patients in cerebral vasospasm. Other agents presented in this report include magnesium, statins, endothelin receptor antagonists, nitric oxide promoters, free radical scavengers, thromboxane inhibitors, thrombolysis, anti-inflammatory agents and neuroprotectants. Although promising data is beginning to emerge for several treatments, few prospective randomized clinical trials are presently available. Additionally, future investigational efforts will need to resolve discrepant definitions and outcome measures for cerebral vasospasm in order to permit adequate study comparisons.
    [Show full text]
  • High Susceptibility of Atherosclerotic Coronary Arteries to the Onset Of
    maco har log P y: r O la u p c e n s a A Koike et al., Cardiol Pharmacol 2015, 4:1 v c o c i e d r s a s Open Access DOI: 10.4172/2329-6607.1000131 C Cardiovascular Pharmacology: ISSN: 2329-6607 Research Article OpenOpen Access Access High Susceptibility of Atherosclerotic Coronary Arteries to the Onset of Vasospasm and Angina Pectoris-like Symptoms due to Coronary Spasm in WHHLMI Rabbits Tomonari Koike1*, Tatsuro Ishida2, Shiori Tamura3, Nobue Kuniyoshi1, Ying Yu1, Satoshi Yamada1, Ken-ichi Hirata2 and Masashi Shiomi1,3 1Institute for Experimental Animals, Kobe University Graduate School of Medicine, Kobe, Japan 2Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 3Division of Comparative Pathophysiology, Kobe University Graduate School of Medicine, Kobe, Japan Abstract Objectives: We examined the relationship between atherosclerosis and provocation of coronary spasm as well as influence of coronary spasm on the onset of acute ischemic myocardial disease. Methods and Results: Coronary spasm was provoked in anesthetized normal Japanese white (JW) rabbits and WHHLMI rabbits, an animal model for coronary atherosclerosis and myocardial infarction, by injecting ergonovine during the infusion of norepinephrine through a marginal ear vein. A decrease in contrast flow in the left circumflex artery was observed on coronary angiograms. Ischemic changes were observed on the electrocardiogram of 29% (2/7) of JW and 79% (27/34) of WHHLMI rabbits. The frequency of coronary spasm was significantly high in rabbits with severe coronary plaques showing diffuse lesions. In addition, the degree of contraction of coronary strips with atherosclerotic plaques was higher than that of normal coronary strips excised from JW rabbits stimulated by a combination of ergonovine and norepinephrine.
    [Show full text]
  • Vasoplegic Syndrome After Oral Nimodipine Application in Patients with Subarachnoid Hemorrhage
    Journal of Anesthesia & Critical Care: Open Access Vasoplegic Syndrome after Oral Nimodipine Application in Patients with Subarachnoid Hemorrhage Abstract Research Article Subarachnoid hemorrhage remains a serious disease with high mortality rate and often disastrous neurological outcome. After improvement of techniques to secure Volume 1 Issue 6 - 2014 the underlying aneurysm leading to decrease of immediate complications such as rebleeding, cerebral vasospasm remains the major cause for mortality and morbidity Bele S1*, Scheitzach J1, Kieninger M2, after subarachnoid hemorrhage. The only FDA approved drug for treatment of cerebral Hochreiter A1, Schödel P1, Bründl E1, Schebesch K-M1 and Brawanksi A1 cerebralvasospasm vasospasm. is the calcium But itantagonist has reported Nimodipine side effects that hassuch shown as systemic beneficial hypotension, effects on 1Department of Neurosurgery, Regensburg University, especiallyoutcome. Itwhen is safe, used cost intravenously. efficient and The the presentmost widely paper studied reports drug about for the treatment occurence of Germany 2 of severe systemic catecholamine refractory hypotension after oral application of the Department of Anaesthesiology, Regensburg University, standard dosage of 60 mg nimodipine. In those patients we were only able to establish Germany *Corresponding author: Sylvia Bele, Department at least part of the underlying mechanism was NO related vasoplegia. Keeping in mind of Neurosurgery, Regensburg University, Franz Josef thata sufficient vasoplegia arterial can bloodoccur evenpressure after after oral applicationnimodipine of application methylene we blue suggest suggesting that there that Strauß Allee 11, 93052 Regensburg , Germany, Tel: should be a test dosage of 15-30 mg nimodipine applied to evaluate the impact on each 499419449071; Email: patient and avoid potential lethal hypotension.
    [Show full text]